A review of Rett syndrome (RTT) with induced pluripotent stem cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Stem Cell Investigation

• Publication date

  2016-09-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.21037/SCI.2016.09.05PMID 27777941PMCID PMC5067363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MeCP2: only 100% will do

  2012cited by this paper
• Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene

  2012cited by this paper
• Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin.

  2012influential reference
• Direct reprogramming of fibroblasts into neural stem cells by defined factors.

  2012cited by this paper
• The Rett Syndrome Protein MeCP2 Regulates Synaptic Scaling

  2012cited by this paper
• Wild type microglia arrest pathology in a mouse model of Rett syndrome

  2012cited by this paper
• Isoform-Specific Toxicity of Mecp2 in Postmitotic Neurons: Suppression of Neurotoxicity by FoxG1

  2012cited by this paper
• Concise Review: Pluripotency and the Transcriptional Inactivation of the Female Mammalian X Chromosome

  2012cited by this paper
• Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.

  2011influential reference
• Chemical strategies for stem cell biology and regenerative medicine.

  2011cited by this paper
• Deriving excitatory neurons of the neocortex from pluripotent stem cells.

  2011cited by this paper
• Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

  2011cited by this paper
• Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation

  2011influential reference
• MeCP2: structure and function.

  2011cited by this paper
• A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.

  2011cited by this paper
• Rett Syndrome Mutation MeCP2 T158A Disrupts DNA Binding, Protein Stability and ERP Responses

  2011cited by this paper
• Somatic coding mutations in human induced pluripotent stem cells

  2011cited by this paper
• Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

  2011cited by this paper
• microRNAs modulate iPS cell generation.

  2011cited by this paper
• Copy number variation and selection during reprogramming to pluripotency

  2011cited by this paper
• Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase.

  2011influential reference
• Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

  2011cited by this paper
• The genetics of neurodevelopmental disease.

  2011cited by this paper
• A role for glia in the progression of Rett’s syndrome

  2011cited by this paper
• Phosphoinositide-3-Kinase Activation Controls Synaptogenesis and Spinogenesis in Hippocampal Neurons

  2011cited by this paper
• Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice.

  2011cited by this paper
• Evolutionary diversity and developmental regulation of X-chromosome inactivation

  2011cited by this paper
• Modelling the long QT syndrome with induced pluripotent stem cells

  2011cited by this paper
• Isogenic Pairs of Wild Type and Mutant Induced Pluripotent Stem Cell (iPSC) Lines from Rett Syndrome Patients as In Vitro Disease Model

  2011influential reference
• The Role of Microglia in the Healthy Brain

  2011cited by this paper
• XCI in preimplantation mouse and human embryos: first there is remodelling…

  2011cited by this paper
• X chromosome inactivation in human and mouse pluripotent stem cells

  2011cited by this paper
• Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons

  2011cited by this paper
• Adult Neural Function Requires MeCP2

  2011cited by this paper
• DNA methylation profiles of human active and inactive X chromosomes.

  2011cited by this paper
• Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

  2011cited by this paper
• Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development

  2011cited by this paper
• iPS cells to model CDKL5-related disorders

  2011influential reference
• Phenotypic checkpoints regulate neuronal development.

  2010cited by this paper
• Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

  2010cited by this paper
• Female human iPSCs retain an inactive X chromosome.

  2010cited by this paper
• Exogenous Brain-Derived Neurotrophic Factor Rescues Synaptic Dysfunction in Mecp2-Null Mice

  2010cited by this paper
• Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

  2010cited by this paper
• Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice.

  2010cited by this paper
• Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

  2010cited by this paper
• Variations of X Chromosome Inactivation Occur in Early Passages of Female Human Embryonic Stem Cells

  2010influential reference
• Rett syndrome and other autism spectrum disorders—brain diseases of immune malfunction?

  2010cited by this paper
• GABAergic dysfunction mediates autism-like stereotypies and Rett syndrome phenotypes

  2010cited by this paper
• A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells.

  2010influential reference
• Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome

  2010cited by this paper
• L1 retrotransposition in neurons is modulated by MeCP2

  2010cited by this paper
• Epigenetic memory in induced pluripotent stem cells

  2010influential reference
• Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations.

  2010cited by this paper
• Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate

  2010cited by this paper
• Modeling complex neuropsychiatric disease with induced pluripotent stem cells

  2010cited by this paper
• Longevity in Rett syndrome: analysis of the North American Database.

  2010cited by this paper
• Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs

  2010cited by this paper
• Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

  2010cited by this paper
• MeCP2 in the Nucleus Accumbens Contributes to Neural and Behavioral Responses to Psychostimulants

  2010cited by this paper
• Early postnatal behavioral changes in the Mecp2‐308 truncation mouse model of Rett syndrome

  2010cited by this paper
• Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders

  2010cited by this paper
• Unconventional Transcriptional Response to Environmental Enrichment in a Mouse Model of Rett Syndrome

  2010cited by this paper
• LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation.

  2010cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.

  2010cited by this paper
• Normal Development of Brain Circuits

  2010cited by this paper
• Faculty Opinions recommendation of Human induced pluripotent stem cells free of vector and transgene sequences.

  2009cited by this paper
• Social approach in genetically engineered mouse lines relevant to autism

  2009cited by this paper
• Microglia: biology and pathology

  2009cited by this paper
• Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency

  2009influential reference
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus

  2009cited by this paper
• Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice

  2009cited by this paper
• Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

  2009cited by this paper
• Supplemental Data Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins

  2009cited by this paper
• Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

  2009cited by this paper
• Skewed X chromosome inactivation in diploid and triploid female human embryonic stem cells.

  2009influential reference
• Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs

  2009cited by this paper
• Induced pluripotent stem cells from a spinal muscular atrophy patient

  2009cited by this paper
• Adult mice generated from induced pluripotent stem cells

  2009cited by this paper
• Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities

  2009cited by this paper
• Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function

  2009cited by this paper
• Pluripotent stem cells and disease modeling.

  2009cited by this paper
• High-resolution analysis of epigenetic changes associated with X inactivation.

  2009cited by this paper
• iPS cells produce viable mice through tetraploid complementation

  2009cited by this paper
• X chromosome inactivation is initiated in human preimplantation embryos.

  2009cited by this paper
• Technical challenges in using human induced pluripotent stem cells to model disease.

  2009cited by this paper
• Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions

  2009cited by this paper
• MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy

  2009cited by this paper
• Widespread changes in dendritic and axonal morphology in Mecp2‐mutant mouse models of rett syndrome: Evidence for disruption of neuronal networks

  2009cited by this paper
• Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology

  2009cited by this paper
• Generation of human-induced pluripotent stem cells

  2008cited by this paper
• X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations

  2008influential reference
• Rett syndrome in adults with severe intellectual disability: Exploration of behavioral characteristics

  2008cited by this paper
• X‐inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected

  2008influential reference
• The methyl-CpG-binding protein MeCP2 and neurological disease.

  2008cited by this paper
• Social approach and repetitive behavior in eleven inbred mouse strains.

  2008cited by this paper
• MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper

• Genetic Instability and Disease Progression of Indian Rett Syndrome Patients

  2023cites this paper
• Advances in iPSC Technology in Neural Disease Modeling, Drug Screening, and Therapy.

  2023cites this paper
• Concurrent Assessment of Oxidative Stress and MT-ATP6 Gene Profiling to Facilitate Diagnosis of Autism Spectrum Disorder (ASD) in Tamil Nadu Population

  2023cites this paper
• KW-2449 and VPA exert therapeutic effects on human neurons and cerebral organoids derived from MECP2-null hESCs

  2022cites this paper
• A late-onset Parkinson's disease in tribes in India – A case report

  2021cites this paper
• Autism spectrum disorder (ASD) – A case-control study to investigate the prenatal, perinatal and neonatal factors in Indian Population

  2021cites this paper
• Role of RhoA-ROCK signaling in Parkinson's disease.

  2020cites this paper
• Drug Studies on Rett Syndrome: From Bench to Bedside

  2020cites this paper
• In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid

  2020cites this paper
• Modeling Rett Syndrome With Human Patient-Specific Forebrain Organoids

  2020cites this paper
• Non-Coding RNAs and Human Diseases

  2020cites this paper
• Characterizing a Novel Mutation in MECP2 using an hiPSC Model of Rett Syndrome

  2020cites this paper
• The Role of Non-Coding RNAs in Neurodevelopmental Disorders

  2019cites this paper
• Translational Medicine Strategies in Drug Development for Neurodevelopmental Disorders

  2019cites this paper
• Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease.

  2017cites this paper
• Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology.

  2017cites this paper
• Using induced pluripotent stem cells derived neurons to model brain diseases

  2017cites this paper
• The Role of Noncoding RNAs in Neurodevelopmental Disorders: The Case of Rett Syndrome.

  2017cites this paper